Distinct immune microenvironments stratify triple-negative breast cancer and predict outcome

被引：4
作者：
Gruosso, T. [1 ]
Gigoux, M. [1 ]
Bertos, N. [1 ]
Manem, V. S. K. [2 ]
Guiot, M. -C. [3 ]
Buisseret, L. [4 ]
Salgado, R. [5 ]
Van den Eyden, G. [5 ]
Haibe-Kains, B. [2 ]
Park, M. [1 ]
机构：
[1] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada
[2] Univ Toronto, Princess Margaret Bioinformat & Computat Genom La, Toronto, ON, Canada
[3] McGill Univ, Hlth Ctr, Pathol, Montreal, PQ, Canada
[4] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium
[5] Jules Bordet Inst, Oncol, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
10.1093/annonc/mdx140.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
50P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Triple-negative breast cancer
    Reinaldo D Chacón
    María V Costanzo
    Breast Cancer Research, 12
  • [22] Clinical outcome of triple-negative (TN) breast cancer (BC)
    Cabuk, D.
    Basaran, G.
    Kaya, H.
    Gulluoglu, B.
    Teomete, M.
    Dane, F.
    Yumuk, P. F.
    Turhal, N. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Laura L. Michel
    Alexandra von Au
    Athanasios Mavratzas
    Katharina Smetanay
    Florian Schütz
    Andreas Schneeweiss
    Targeted Oncology, 2020, 15 : 415 - 428
  • [24] Immune-related biomarkers in triple-negative breast cancer
    Juan Zhang
    Qi Tian
    Mi Zhang
    Hui Wang
    Lei Wu
    Jin Yang
    Breast Cancer, 2021, 28 : 792 - 805
  • [25] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Michel, Laura L.
    von Au, Alexandra
    Mavratzas, Athanasios
    Smetanay, Katharina
    Schuetz, Florian
    Schneeweiss, Andreas
    TARGETED ONCOLOGY, 2020, 15 (04) : 415 - 428
  • [26] Novel immune targets for the treatment of triple-negative breast cancer
    Corti, Chiara
    Nicolo, Eleonora
    Curigliano, Giuseppe
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (10) : 815 - 834
  • [27] Comparison of tumor immune microenvironments (TIMEs) between primary and metastatic sites (Mets) in triple-negative breast cancer (TNBC)
    Yuan, Yuan
    Kang, Irene
    Bitar, Jin Sun
    Davis, Andrew A.
    Hilton, Christie
    Huang, Minxuan
    Thompson, Michael A.
    Mercer, Jacob
    Shiao, Stephen Lawrence
    Vail, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
    Ivana Zagorac
    Sara Fernandez-Gaitero
    Renske Penning
    Harm Post
    Maria J. Bueno
    Silvana Mouron
    Luis Manso
    Manuel M. Morente
    Soledad Alonso
    Violeta Serra
    Javier Muñoz
    Gonzalo Gómez-López
    Jose Francisco Lopez-Acosta
    Veronica Jimenez-Renard
    Albert Gris-Oliver
    Fatima Al-Shahrour
    Elena Piñeiro-Yañez
    Jose Luis Montoya-Suarez
    Juan V. Apala
    Amalia Moreno-Torres
    Ramon Colomer
    Ana Dopazo
    Albert J. R. Heck
    Maarten Altelaar
    Miguel Quintela-Fandino
    Nature Communications, 9
  • [29] In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
    Zagorac, Ivana
    Fernandez-Gaitero, Sara
    Penning, Renske
    Post, Harm
    Bueno, Maria J.
    Mouron, Silvana
    Manso, Luis
    Morente, Manuel M.
    Alonso, Soledad
    Serra, Violeta
    Munoz, Javier
    Gomez-Lopez, Gonzalo
    Francisco Lopez-Acosta, Jose
    Jimenez-Renard, Veronica
    Gris-Oliver, Albert
    Al-Shahrour, Fatima
    Pineiro-Yanez, Elena
    Luis Montoya-Suarez, Jose
    Apala, Juan V.
    Moreno-Torres, Amalia
    Colomer, Ramon
    Dopazo, Ana
    Heck, Albert J. R.
    Altelaar, Maarten
    Quintela-Fandino, Miguel
    NATURE COMMUNICATIONS, 2018, 9
  • [30] SLC1A5 to predict outcome with chemotherapy in early triple-negative breast cancer.
    Affan, Anna Maria
    Varadan, Vinay
    Gilmore, Hannah L.
    Miskimen, Kristy
    Jeon, Young Joo
    Parsai, Shikha
    Ronai, Ze'ev
    Harris, Lyndsay
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345